ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Oral Ribavirin Therapy for Respiratory Syncytial Virus Infections in Moderately to Severely Immunocompromised Patients

    J. Marcelin, J. Wilson, R. Razonable

    Mayo Clinic, Rochester, MN

    BackgroundRespiratory syncytial virus (RSV) can be fatal in immunocompromised patients. Aerosolized ribavirin is used for treatment but it is costly, teratogenic, and inconvenient. We aimed…
  • 2013 American Transplant Congress

    Utilization of Kidneys from Donors after Circulatory Death in China: An Initial Report from a Single Center

    G. Chen, D. Ko, C. Wang, J. Qiu, M. Han, X. He, L. Chen

    Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China; Departments of Urology and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    In 2007, a landmark decision that is supported by the international transplant community, the Chinese national government has established regulations to gradually abolish the use…
  • 2013 American Transplant Congress

    Outcomes of Switching to Belatacept from a Calcineurin Inhibitor in Kidney Transplant Recipients: 3 Year Results from the Long-Term Extension of a Phase II Study

    J. Grinyo, M. Rial, J. Alberu, S. Steinberg, R. Manfro, G. Nainan, F. Vincenti, C. Jones-Burton, N. Kamar

    Hosp Univ de Bellvitge, Spain; Inst de Nefrologia, Argentina; Inst Nacional de Ciencias Medicas y Nutricion, Mexico; Balboa Inst of Transpl, CA; Hosp de Clinicas de Porto Alegre, Brazil; Lakeshore Hosp, India; UCSF, CA; BMS, NJ; University Hosp, France

    Introduction: There remains a need for immunosuppressive agents which offer long-term preservation of renal function and an acceptable safety profile in the switch setting. Here…
  • 2013 American Transplant Congress

    Polyoma BK-Virus-Specific T Cells as a Surrogate Marker for Polyomavirus-Associated Nephropathy after Pediatric Kidney Transplantation

    T. Ahlenstiel, U. Sester, H. Fehrenbach, L. Pape

    Pediatric Nephrology, Hannover Medical School, Hannover, Germany; Nephrology and Hypertension, University of the Saarland, Homburg (Saar), Germany; Pediatrics, Klinikum Memmingen, Memmingen, Germany

    After kidney transplantation (KTx) immunosuppressive therapy causes impaired cellular immune defense resulting in increased risk of polyomavirus-associated nephropathy (PVAN). Prognostic markers for the outcome of…
  • 2013 American Transplant Congress

    Molecular Markers To Distinguish Modes of Renal Graft Rejection

    M. Mikula, K. Livingston, O. Zhukov, F. Hantash, K. Zhang, J. Rion, P. Putheti, C. Snopkowski, A. Buller-Burckle, J. Popov, W. Sun, B. Crossley, M. Hernandez-Fuentes, S. Sacks, M. Suthanthiran, T. Strom, C. Strom, S. Naides

    Quest Diagnostics Nichols Institute, SJC, CA; Beth Israel Deaconess Medical Center, Boston, MA; NY Presbyterian Hospital-Weill Cornell Medical Center, NYC, NY; King's College, London, England, United Kingdom

    Renal transplant recipients may suffer serious consequences from graft rejection. We sought to develop an accurate, noninvasive test that can detect and distinguish acute cellular…
  • 2013 American Transplant Congress

    Role of Commensal Microbiota in Skin Allograft Rejection

    C. Bartman, Y. Wang, P. Zhou, L. Molinero, M. Alegre

    Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL

    A multitude of recent studies have demonstrated that the intestinal microbiota influences systemic autoimmunity and immune responses to infection. Organs associated with commensal bacteria, including…
  • 2013 American Transplant Congress

    Time to Presentation of Donor Derived Infection

    D. Kaul, E. Dominguez, N. Siparsky, C. Wolfe, S. Taranto, S. Covington, E. Blumberg, M. Green

    OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC), Richmond, VA; United Network for Organ Sharing, Richmond, VA

    Background: Differentiating donor-derived infection (DDI) from other causes of illness after solid organ transplantation (SOT) can be challenging. Early recognition of potential DDI allows treatment/prevention…
  • 2013 American Transplant Congress

    CD40-Dependent Help by CD4 T Cells Is Required for CD8 T Cell Recovery after Antithymocyte Globulin Lymphoablation

    K. Ayasoufi, X. Wang, H. Yu, A. Valujskikh

    The Cleveland Clinic, Cleveland

    Antithymocyte globulin (ATG) is a lymphoablative agent used in transplant patients. However, ATG treated recipients eventually reconstitute their T cell repertoire, develop anti-donor immune responses…
  • 2013 American Transplant Congress

    Significant Impact of Prolonged Brain Death Duration on Patient Survival after Kidney Transplantation

    A. Weissenbacher, R. Oberhuber, S. Weiss, B. Cardini, C. Bösmüller, S. Schneeberger, J. Pratschke, R. Öllinger

    Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Tyrol, Austria

    Introduction: In renal transplantation, graft survival using organs from deceased donors is inferior to results after living donation. Little however is known about the effect…
  • 2013 American Transplant Congress

    Follicular Helper T Cell Modulation by Costimulation Blockade Prevents Antibody-Mediated Rejection in Nonhuman Primate Renal Transplantation

    J. Kwun, E. Page, A. Gibby, J. Hong, A. Farris, A. Adams, N. Iwakoshi, C. Larsen, A. Kirk, S. Knechtle

    Surgery, Emory University, Atlanta, GA; Pathology, Emory University, Atlanta, GA

    [Background] De novo donor-specific antibody (DSA) after organ transplantation promotes antibody-mediated rejection (AMR) and causes late graft loss. Nearly a third of transplant recipients develop…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences